0 items

in your cart
$0.00

Prescription Drug Search

Strengths available for Cedax:

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Cedax:

  • Albania
  • Algeria
  • Anguilla
  • Argentina
  • Austria
  • Azerbaijan
  • Bangladesh
  • Barbados
  • Belarus
  • Bermuda
  • Chile
  • China
  • Colombia
  • Cook Islands
  • Cuba
  • Denmark
  • Ecuador
  • European Union
  • Finland
  • France
  • India
  • Italy
  • Japan
  • Jordan
  • Kuwait
  • Lebanon
  • Morocco
  • Netherlands
  • Netherlands Antilles
  • Panama
  • Paraguay
  • Sri Lanka
  • Switzerland
  • Thailand
  • Tonga
  • Ukraine
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Venezuela
View All Countries

Latest news releases on Cedax:

Pernix Therapeutics Reports First Quarter 2012 Financial Results - Yahoo Finance

The growth in net revenues was due primarily to a higher volume of sales of CEDAX, certain generic products and a decrease in Medicaid rebates. Net income for the first quarter of 2012 was approximately $1.2 million, or $0.05 per basic and $0.04 ...

Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Upside Scenarios Outweigh Downside Risks - StreetInsider.com

Despite weak cough and cold season and increasingly disappointing Natroba sales, 1Q12 revenues increased 43% y/y due to higher sales of Cedax and generic products. Near-term focus now shifts to expansion into gastroenterology with 2H12 launch of Omeclamox ...

Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio - PR Newswire

The Company manages a portfolio of branded and generic products. The Company's branded products for the pediatrics market include CEDAX®, an antibiotic for middle ear infections, NATROBA™, a topical treatment for head lice marketed under an exclusive co ...

Pernix Therapeutics Holdings Inc : Pernix Therapeutics Reports First Quarter 2012 Financial Results - 4-traders (press release)

The growth in net revenues was due primarily to a higher volume of sales of CEDAX, certain generic products and a decrease in Medicaid rebates. Net income for the first quarter of 2012 was approximately $1.2 million, or $0.05 per basic and $0.04 per ...

Pernix Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference - Yahoo Finance

The Company’s branded products for the pediatrics market include CEDAX®, an antibiotic for middle ear infections, NATROBA™, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC, a family of ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK